Drug Neurology

Vumerity

Payments companies reported to CMS as associated with Vumerity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4.8Massociated payments (2023-2025)
6,803clinicians with associated payments
1company reporting

By year

2023 $1.9M
2024 $1.3M
2025 $1.5M

Payments reported as associated with Vumerity, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $3.9M
Family $219K
Physician Assistant $93K
Nurse Practitioner $90K
Neuromuscular Medicine (Psychiatry & Neurology) $81K
Adult Health (Nurse Practitioner) $46K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vumerity

These are the largest totals companies reported as associated with Vumerity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Daniel Bandari Newport Beach, CA Neurology (Psychiatry & Neurology) $204,177.51
Regina Berkovich West Hollywood, CA Neurology (Psychiatry & Neurology) $85,306.96
Derrick Robertson Tampa, FL Neurology (Psychiatry & Neurology) $72,818.04
Barry Hendin Phoenix, AZ Neurology (Psychiatry & Neurology) $71,321.13
Mark Tullman Saint Louis, MO Neurology (Psychiatry & Neurology) $70,808.19
Amparo Gutierrez Orlando, FL Neuromuscular Medicine (Psychiatry & Neurology) $61,698.40
Angel Chinea Guaynabo, PR Neurology (Psychiatry & Neurology) $59,621.77
David Clark Springfield, OR Neurology (Psychiatry & Neurology) $55,210.61
Kenneth Mankowski Columbus, OH Neurology (Psychiatry & Neurology) $55,110.03
Matthew Baker Naples, FL Neurology (Psychiatry & Neurology) $54,908.50

Prescribed Vumerity?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.